{"url_path":"/sec/oaccw/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/2029769/0001193125-26-221814-index.html","accession_number":"0001193125-26-221814","cik":"0002029769","ticker":"OACC","issuer_name":"Oaktree Acquisition Corp. III Life Sciences","edgar_url":"https://www.sec.gov/Archives/edgar/data/2029769/0001193125-26-221814-index.html","primary_entity_key":"0002029769","primary_entity_name":"Oaktree Acquisition Corp. III Life Sciences"},"word_count":255,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\nThe following exhibits are filed as part of, or incorporated by reference into, this Report.\n\n \n\nNo.\n  \n\nDescription of Exhibit\n\n 31.1*\n  \n[Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](d787030dex311.htm)\n\n 31.2*\n  \n[Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](d787030dex312.htm)\n\n 32.1**\n  \n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](d787030dex321.htm)\n\n 32.2**\n  \n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](d787030dex322.htm)\n\n101.INS*\n  \nXBRL Instance Document.\n\n101.SCH*\n  \nXBRL Taxonomy Extension Schema Document.\n\n101.CAL*\n  \nXBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEF*\n  \nXBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LAB*\n  \nXBRL Taxonomy Extension Labels Linkbase Document.\n\n101.PRE*\n  \nXBRL Taxonomy Extension Presentation Linkbase Document.\n\n104*\n  \nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*\n\nFiled herewith.\n\n**\n\nFurnished herewith.\n\n \n\n23\n\n##### Table of Contents\n\nSIGNATURES\n\nIn accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \n\n \nOAKTREE ACQUISITION CORP. III LIFE SCIENCES\n\nDate: May 13, 2026\n \n\n \nBy:\n \n/s/ Zaid Pardesi\n\n \n\n \nName:\n \nZaid Pardesi\n\n \n\n \nTitle:\n \nChief Executive Officer\n\n \n\n \n\n \n(Principal Executive Officer)\n\nDate: May 13, 2026\n \n\n \nBy:\n \n/s/ George A. Martinez\n\n \n\n \nName:\n \nGeorge A. Martinez\n\n \n\n \nTitle:\n \nChief Financial Officer\n\n \n\n \n\n \n(Principal Financial and Accounting Officer)\n\n \n\n24"}